CoChat

Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism

Open access
Ku, Seockmo, Park, Myeong, Ji, Geun, You, Hyun · 2016 · International Journal of Molecular Sciences
Cited by 106

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Bifidobacterium bifidum BGN4 is a probiotic strain that has been used as a major ingredient to produce nutraceutical products and as a dairy starter since 2000. The various bio-functional effects and potential for industrial application of B. bifidum BGN4 has been characterized and proven by in vitro (i.e., phytochemical bio-catalysis, cell adhesion and anti-carcinogenic effects on cell lines, and immunomodulatory effects on immune cells), in vivo (i.e., suppressed allergic responses in mouse model and anti-inflammatory bowel disease), and clinical studies (eczema in infants and adults with irritable bowel syndrome). Recently, the investigation of the genome sequencing was finished and this data potentially clarifies the biochemical characteristics of B. bifidum BGN4 that possibly illustrate its nutraceutical functionality. However, further systematic research should be continued to gain insight for academic and industrial applications so that the use of B. bifidum BGN4 could be expanded to result in greater benefit. This review deals with multiple studies on B. bifidum BGN4 to offer a greater understanding as a probiotic microorganism available in functional food ingredients. In particular, this work considers the potential for commercial application, physiological characterization and exploitation of B. bifidum BGN4 as a whole.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms17091544

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 125

  1. Syngai, 2015, Probiotics—The versatile vunctional food ingredients, J. Food Sci. Technol., 53, 921, 10.1007/s13197-015-2011-0 · DOI
  2. Mauriello, 2016, Probiotication of foods: A focus on microencapsulation tool, Trends Food Sci. Technol., 48, 27, 10.1016/j.tifs.2015.11.009 · DOI · Paper page
  3. Yildiz, F. (2010). Development and Manufacture of Yogurt and Other Functional Dairy Products, CRC Press/Taylor & Francis. · DOI
  4. Preedy, V. (2012). Handbook of Diet, Nutrition and The Skin, Wageningen Academic Publisher. · doi:10.3920/978-90-8686-729-5
  5. Sarkar, 2016, Probiotics: A way of value addition in functional food, Int. J. Food Sci. Nutr. Diet., 5, 290
  6. Tajabadi, 2015, Optimization Of γ-Aminobutyric acid production by Lactobacillus plantarum Taj-Apis362 from honeybees, Molecules, 20, 6654, 10.3390/molecules20046654 · DOI
  7. Ku, 2016, Finding and producing probiotic glycosylases for the biocatalysis of ginsenosides: A mini review, Molecules, 21, 645, 10.3390/molecules21050645 · DOI
  8. Soto, 2014, Lactobacilli and bifidobacteria in human bBreast milk: Influence of antibiotherapy and other host and clinical factors, J. Pediatr. Gastroenterol. Nutr., 59, 78, 10.1097/MPG.0000000000000347 · DOI · Paper page
  9. Farver, 2015, The influence of early infant-feeding practices on the intestinal microbiome and body composition in infants, Nutr. Metab. Insights, 8, 1
  10. Grguric, 1996, Microflora in the digestive tract of infants, Mljekarstvo, 46, 291
  11. Saavedra, 2007, Use of probiotics in pediatrics: Rationale, mechanisms of action, and practical aspects, Nutr. Clin. Pract., 22, 351, 10.1177/0115426507022003351 · DOI · Paper page
  12. Lewis, Z.T., Totten, S.M., Smilowitz, J.T., Popovic, M., Parker, E., Lemay, D.G., van Tassell, M.L., Miller, M.J., Jin, Y.S., and German, J.B. (2015). Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome, 3. · DOI · Paper page
  13. Harmsen, 2000, Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods, J. Pediatr. Gastroenterol. Nutr., 30, 61
  14. Aggett, 2003, Nondigestible carbohydrates in the diets of infants and young children: A commentary by the ESPGHAN Committee on Nutrition, J. Pediatr. Gastroenterol. Nutr., 36, 329
  15. Turroni, F., Duranti, S., Bottacini, F., Guglielmetti, S., van Sinderen, D., and Ventura, M. (2014). Bifidobacterium bifidum as an example of a specialized human gut commensal. Front. Microbiol., 5. · DOI · Paper page
  16. Wang, 2013, Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora, World J. Microbiol. Biotechnol., 30, 847, 10.1007/s11274-013-1490-2 · DOI
  17. Culpepper, 2016, Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: A secondary analysis of a randomised trial, Benef. Microbes, 7, 327, 10.3920/BM2015.0156 · DOI
  18. Choi, 1996, Growth and β-Glucosidase activity of bifidobacterium, J. Microbiol. Biotechnol., 6, 255
  19. Kim, 2003, Characterization of adhesion of Bifidobacterium sp. BGN4 to human enterocyte-like Caco-2 cells, J. Microbiol. Biotechnol., 13, 276
  20. Ku, 2009, Enhancement of anti-tumorigenic polysaccharide production, adhesion, and branch formation of Bifidobacterium bifidum BGN4 by phytic acid, Food Sci. Biotechnol., 18, 749
  21. Lee, 2002, Cytoskeleton reorganization and cytokine production of macrophages by bifidobacterial cells and cell-free extracts, J. Microbiol. Biotechnol., 12, 398
  22. Kim, 2006, Modulatory activity of Bifidobacterium sp. BGN4 cell fractions on immune cells, J. Microbiol. Biotechnol., 16, 584
  23. Lee, 2006, Regulatory effect on specific ige response of Bifidobacterium bifidum (BGN4 Strain) in murine model of peanut allergy, J. Allergy Clin. Immunol., 117, S204, 10.1016/j.jaci.2005.12.806 · doi:10.1016/j.jaci.2005.12.806
  24. Kim, 2007, Oral feeding of Bifidobacterium bifidum (BGN4) Prevents CD4 + CD45RB high T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation, Clin. Immunol., 123, 30, 10.1016/j.clim.2006.11.005 · DOI
  25. Kim, 2010, Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial, Pediatr. Allergy Immunol., 21, 386, 10.1111/j.1399-3038.2009.00958.x · DOI · Paper page
  26. Kim, 2012, Probiotic modulation of dendritic cells co-cultured with intestinal epithelial cells, World J. Gastroenterol., 18, 1308, 10.3748/wjg.v18.i12.1308 · DOI
  27. You, 2004, Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4, FEMS Microbiol. Lett., 240, 131, 10.1016/j.femsle.2004.09.020 · DOI
  28. Youn, 2012, Identification of the β-glucosidase gene from Bifidobacterium animalis Subsp. Lactis and its expression in B. bifidum BGN4, J. Microbiol. Biotechnol., 22, 1714, 10.4014/jmb.1208.08028 · doi:10.4014/jmb.1208.08028
  29. Kim, 2012, Cloning and expression of β-Glucosidases from Bifidobacterium lactis AD011, Food Sci. Biotechnol., 21, 731, 10.1007/s10068-012-0095-0 · DOI
  30. Wang, 2012, Novel Bifidobacterium promoters selected through microarray analysis lead to constitutive high-level gene expression, J. Microbiol., 50, 638, 10.1007/s12275-012-1591-x · DOI
  31. Kim, 2014, Production of γ-aminobutyric acid during fermentation of Gastrodia Elata Bl. By co-culture of Lactobacillus brevis GABA 100 with Bifidobacterium bifidum BGN4, Food Sci. Biotechnol., 23, 459, 10.1007/s10068-014-0063-y · DOI
  32. You, 2015, High expression of β-glucosidase in Bifidobacterium bifidum BGN4 and application in conversion of isoflavone glucosides during fermentation of soy milk, J. Microbiol. Biotechnol., 25, 469, 10.4014/jmb.1408.08013 · DOI
  33. Kim, 2008, Development of S-adenosyl-l-methionine (SAM)-reinforced probiotic yogurt using Bifidobacterium bifidum BGN4, Food Sci. Biotechnol., 17, 1025
  34. Kim, 2008, Evaluation of S-adenosyl-l-methionine production by Bifidobacterium bifidum BGN4, Food Sci. Biotechnol., 17, 184
  35. Yu, 2012, Complete genome sequence of the probiotic bacterium Bifidobacterium bifidum strain BGN4, J. Bacteriol., 194, 4757, 10.1128/JB.00988-12 · DOI
  36. Ribet, 2015, How bacterial pathogens colonize their hosts and invade deeper tissues, Microbes Infect., 17, 173, 10.1016/j.micinf.2015.01.004 · DOI · Paper page
  37. Brandt, 2015, Acetylated rhamnogalacturonans from immature fruits of Abelmoschus esculentus inhibit the adhesion of Helicobacter pylori to human gastric cells by interaction with outer membrane proteins, Molecules, 20, 16770, 10.3390/molecules200916770 · doi:10.3390/molecules200916770
  38. Kim, 2015, Fructooligosaccharides decreased the ability of probiotic Escherichia coli Nissle 1917 to adhere to co-cultures of human intestinal cell lines, J. Korean Soc. Appl. Biol. Chem., 58, 45, 10.1007/s13765-015-0002-5 · DOI
  39. Serafini, 2013, Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010, Anaerobe, 21, 9, 10.1016/j.anaerobe.2013.03.003 · DOI
  40. Underwood, 2012, Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: Antimicrobial peptide and protein responses, Pediatr. Res., 71, 546, 10.1038/pr.2012.11 · DOI
  41. Martinez, 2013, Bacteriocin production by Bifidobacterium spp: A review, Biotechnol. Adv., 31, 482, 10.1016/j.biotechadv.2013.01.010 · DOI · Paper page
  42. Mandal, 2014, Recombinant probiotics with antimicrobial peptides: A dual strategy to improve immune response in immunocompromised patients, Drug Discov. Today, 19, 1045, 10.1016/j.drudis.2014.05.019 · DOI
  43. Aronsson, L., Huang, Y., Parini, P., Korach-André, M., Håkansson, J., Gustafsson, J., Pettersson, S., Arulampalam, V., and Rafter, J. (2010). Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS ONE, 5. · DOI · Paper page
  44. DiBaise, 2012, Impact of the gut microbiota on the development of obesity: Current concepts, Am. J. Gastroenterol. Suppl., 1, 22, 10.1038/ajgsup.2012.5 · DOI · Paper page
  45. Hardy, 2013, Probiotics, prebiotics and immunomodulation of gut mucosal defences: Homeostasis and immunopathology, Nutrients, 5, 1869, 10.3390/nu5061869 · DOI · Paper page
  46. Yu, 2010, Ability of Lactobacillus to inhibit enteric pathogenic bacteria adhesion on Caco-2 cells, World J. Microbiol. Biotechnol., 27, 881, 10.1007/s11274-010-0530-4 · DOI
  47. Kim, 2014, Evaluation of two Bacillus subtilis strains isolated from Korean fermented food as probiotics against loperamide-induced constipation in mice, J. Korean Soc. Appl. Biol. Chem., 57, 797, 10.1007/s13765-014-4106-0 · DOI
  48. Lim, 2014, Anti-helicobacter pylori activity of antimicrobial substances produced by lactic acid bacteria isolated from Baikkimchi, J. Korean Soc. Appl. Biol. Chem., 57, 621, 10.1007/s13765-014-4198-6 · DOI
  49. Miller, 2011, Lactobacillus adhesion to mucus, Nutrients, 3, 613, 10.3390/nu3050613 · DOI · Paper page
  50. Duary, 2011, Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells, Indian J. Med. Res., 134, 664, 10.4103/0971-5916.90992 · DOI · Paper page
  51. Paduch, 2014, The effect of cell surface components on adhesion ability of Lactobacillus rhamnosus, Antonie van Leeuwenhoek, 106, 751, 10.1007/s10482-014-0245-x · DOI · Paper page
  52. Krasowska, 2014, How microorganisms use hydrophobicity and what does this mean for human needs?, Front. Cell. Infect. Microbiol., 4, 112, 10.3389/fcimb.2014.00112 · DOI · Paper page
  53. Pelletier, 1997, Cell surface characteristics of Lactobacillus casei subsp. casei, Lactobacillus paracasei subsp. paracasei, and Lactobacillus rhamnosus strains, Appl. Environ. Microbiol., 63, 1725, 10.1128/aem.63.5.1725-1731.1997 · DOI · Paper page
  54. Abdulla, 2014, Adhesion, Autoaggregation and hydrophobicity of six Lactobacillus strains, Br. Microbiol. Res. J., 4, 381, 10.9734/BMRJ/2014/6462 · DOI · Paper page
  55. Boris, 1998, Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens, Infect. Immun., 66, 1985, 10.1128/IAI.66.5.1985-1989.1998 · DOI · Paper page
  56. Shakirova, 2010, Influence of growth conditions on hydrophobicity of Lactobacillus acidophilus and Bifidobacterium lactis cells and characteristics by FT-IR spectra, J. Spectrosc., 24, 251, 10.1155/2010/659167 · doi:10.1155/2010/659167
  57. Minnaard, 1998, Surface properties of bifidobacterial strains of human origin, J. Microbiol. Biotechnol., 64, 21
  58. Pan, 2006, The correlation between surface hydrophobicity and adherence of Bifidobacterium strains from centenarians’ faeces, Anaerobe, 12, 148, 10.1016/j.anaerobe.2006.03.001 · DOI
  59. Schillinger, 2005, In vitro adherence and other properties of lactobacilliused in probiotic yoghurt-like products, Int. Dairy J., 15, 1289, 10.1016/j.idairyj.2004.12.008 · DOI · Paper page
  60. Alzate, 2008, Comparison of biotransformation of inorganic selenium by Lactobacillus and Saccharomyces in lactic fermentation process of yogurt and kefir, J. Agric. Food Chem., 56, 8728, 10.1021/jf8013519 · DOI · Paper page
  61. Botes, 2008, Adhesion of the probiotic strains enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to Caco-2 cells under conditions simulating the intestinal tract, and in the presence of antibiotics and anti-inflammatory medicaments, Arch. Microbiol., 190, 573, 10.1007/s00203-008-0408-0 · DOI
  62. Andersson, 1987, Surface properties of lactobacilli isolated from the small intestine of pigs, J. Appl. Bacteriol., 62, 513, 10.1111/j.1365-2672.1987.tb02683.x · DOI · Paper page
  63. Candela, 2008, Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production, Int. J. Food Microbiol., 125, 286, 10.1016/j.ijfoodmicro.2008.04.012 · DOI · Paper page
  64. Crociani, 1995, Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with in vivo study, Lett. Appl. Microbiol., 21, 146, 10.1111/j.1472-765X.1995.tb01027.x · DOI · Paper page
  65. Borchers, 2009, Probiotics and immunity, J. Gastroenterol., 44, 26, 10.1007/s00535-008-2296-0 · DOI · Paper page
  66. Galdeano, 2007, Proposed model: Mechanisms of immunomodulation induced by probiotic bacteria, Clin. Vaccine Immunol., 14, 485, 10.1128/CVI.00406-06 · DOI · Paper page
  67. Kim, 2015, Different shapes of Al2O3 particles induce differential cytotoxicity via a mechanism involving lysosomal destabilization and reactive oxygen species generation, J. Korean Soc. Appl. Biol. Chem., 58, 433, 10.1007/s13765-015-0038-6 · DOI
  68. Li, 2016, Chemical structure and immunomodulating activities of an α-glucan purified from Lobelia chinensis lour, Molecules, 21, 779, 10.3390/molecules21060779 · DOI
  69. Cui, 2016, Regulation of Candida albicans interaction with macrophages through the activation of HOG pathway by genistein, Molecules, 21, 162, 10.3390/molecules21020162 · DOI
  70. Fong, F.L., Shah, N.P., Kirjavainen, P., and El-Nezami, H. (2015). Mechanism of action of probiotic bacteria on intestinal and systemic immunities and antigen-presenting cells. Int. Rev. Immunol., 1–11. · DOI · Paper page
  71. Pourhoseingholi, 2012, Increased burden of colorectal cancer in Asia, World J. Gastrointest. Oncol., 4, 68, 10.4251/wjgo.v4.i4.68 · DOI
  72. Kumar, 2012, Probiotic metabolites as epigenetic targets in the prevention of colon cancer, Nutr. Rev., 71, 23, 10.1111/j.1753-4887.2012.00542.x · DOI · Paper page
  73. Uccello, M., Malaguarnera, G., Basile, F., D’agata, V., Malaguarnera, M., Bertino, G., Vacante, M., Drago, F., and Biondi, A. (2012). Potential role of probiotics on colorectal cancer prevention. BMC Surg., 12. · DOI · Paper page
  74. Raman, M., Ambalam, P., and Doble, M. (2016). Probiotics and Bioactive Carbohydrates in Colon Cancer Management, Springer (India) Pvt. Ltd. · DOI
  75. Mohammadi, 2014, Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain, Iran J. Basic Med. Sci., 17, 815
  76. Nagaoka, 1994, Anti-ulcer effects of lactic acid bacteria and their cell wall polysaccharides, Biol. Pharm. Bull., 17, 1012, 10.1248/bpb.17.1012 · DOI · Paper page
  77. Li, 2005, Caco-2 cell permeability assays to measure drug absorption, Expert Opin. Drug. Metab. Toxicol., 1, 175, 10.1517/17425255.1.2.175 · DOI · Paper page
  78. Corpet, 2002, Most effective colon cancer chemopreventive agents in rats: A systematic review of aberrant crypt foci and tumor data, ranked by potency, Nutr. Cancer, 43, 1, 10.1207/S15327914NC431_1 · DOI · Paper page
  79. Kim, 2008, Aberrant crypt focus size predicts distal polyp histopathology, Cancer Epidemiol. Biomark. Prev., 17, 1155, 10.1158/1055-9965.EPI-07-2731 · doi:10.1158/1055-9965.epi-07-2731
  80. Foerst, P., and Santivarangkna, C. (2015). Advances in Probiotic Technology, CRC Press/Taylor & Francis.
  81. Daniel, 2013, Probiotics from research to market: The possibilities, risks and challenges, Curr. Opin. Microbiol., 16, 284, 10.1016/j.mib.2013.06.008 · DOI · Paper page
  82. Nedović, V., Raspor, P., Lević, J., Tumbas Šaponjac, V., and Barbosa-Cánovas, G. (2016). Emerging and Traditional Technologies for Safe, Healthy and Quality Food, Springer International Publishing. · DOI
  83. Park, 2012, Whole cell biotransformation of major ginsenosides using leuconostocs and lactobacilli, Food Sci. Biotechnol., 21, 839, 10.1007/s10068-012-0108-z · doi:10.1007/s10068-012-0108-z
  84. You, 2010, Transformation of Rutin to antiproliferative quercetin-3-glucoside by Aspergillus niger, J. Agric. Food Chem., 58, 10886, 10.1021/jf102871g · DOI
  85. Ku, 2011, Optimization of β-glucuronidase activity from Lactobacillus delbrueckii Rh2 and its use for biotransformation of baicalin and wogonoside, J. Korean Soc. Appl. Biol. Chem., 54, 275, 10.3839/jksabc.2011.043 · DOI
  86. Ku, 2015, Effects of ascorbic acid on α-l-arabinofuranosidase and α-l-arabinopyranosidase activities from Bifidobacterium longum RD47 and its application to whole cell bioconversion of ginsenoside, J. Korean Soc. Appl. Biol. Chem., 58, 857, 10.1007/s13765-015-0113-z · DOI
  87. Ku, 2016, Whole-cell biocatalysis for producing ginsenoside Rd from Rb1 using Lactobacillus rhamnosus GG, J. Microbiol. Biotechnol., 26, 1206, 10.4014/jmb.1601.01002 · doi:10.4014/jmb.1601.01002
  88. Gao, 2013, Biotransformation, a promising technology for anti-cancer drug development, Asian Pac. J. Cancer Prev., 14, 5599, 10.7314/APJCP.2013.14.10.5599 · doi:10.7314/apjcp.2013.14.10.5599
  89. Sasidharan, 2011, Extraction, isolation and characterization of bioactive compounds from plants’ extracts, Afr. J. Tradit. Complement Altern. Med., 8, 1
  90. Han, 1982, Degradation of ginseng saponins under mild acidic conditions, Planta Med., 44, 146, 10.1055/s-2007-971425 · DOI
  91. Chen, 1987, Alkaline cleavage of ginsenosides, Chem. Pharm. Bull., 35, 1653, 10.1248/cpb.35.1653 · doi:10.1248/cpb.35.1653
  92. Nag, S.A., Qin, J.J., Wang, W., Wang, M.H., Wang, H., and Zhang, R. (2012). Ginsenosides as anticancer agents: In vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front. Pharmacol., 3. · DOI · Paper page
  93. Taku, 2011, Soy isoflavones for osteoporosis: An evidence-based approach, Maturitas, 70, 333, 10.1016/j.maturitas.2011.09.001 · DOI
  94. Orgaard, 2008, The effects of soy isoflavones on obesity, Exp. Biol. Med., 233, 1066, 10.3181/0712-MR-347 · DOI · Paper page
  95. Lu, 2008, Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats, Nutr. Res., 28, 464, 10.1016/j.nutres.2008.03.009 · DOI
  96. Rafii, 2015, The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol, Metabolites, 5, 56, 10.3390/metabo5010056 · DOI · Paper page
  97. Kennedy, 1995, The evidence for soybean products as cancer preventive agents, J. Nutr., 125, 733, 10.1093/jn/125.3_Suppl.733S · DOI · Paper page
  98. Bawa, 2010, The significance of soy protein and soy bioactive compounds in the prophylaxis and treatment of osteoporosis, J. Osteoporos., 2010, 1, 10.4061/2010/891058 · DOI
  99. Kuo, 2012, A process for high-efficiency isoflavone deglycosylation using Bacillus subtilis natto NTU-18, Appl. Microbiol. Biotechnol., 94, 1181, 10.1007/s00253-012-3884-8 · DOI
  100. Hayakawa, 2004, Effect of a γ-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats, Br. J. Nutr., 92, 411, 10.1079/BJN20041221 · DOI · Paper page
  101. Adeghate, 2002, GABA in the endocrine pancreas: Cellular localization and function in normal and diabetic rats, Tissue Cell, 34, 1, 10.1054/tice.2002.0217 · DOI · Paper page
  102. Mazzacane, 2009, Synthesis of γ-aminobutyric acid (GABA) by Lactobacillus plantarum DSM19463: Functional grape must beverage and dermatological applications, Appl. Microbiol. Biotechnol., 86, 731
  103. Li, H., Qiu, T., Huang, G., and Cao, Y. (2010). Production of γ-aminobutyric acid by Lactobacillus brevis NCL912 using fed-batch fermentation. Microb. Cell Fact., 9. · DOI · Paper page
  104. Huh, 1995, Effect of the ether fraction of Gastrodia elata methanol extract on the pentylenetetrazole-induced seizures, J. Appl. Pharmacol., 3, 199
  105. Lee, 2012, Effects of acidic polysaccharides from Gastrodia rhizome on systolic blood pressure and serum lipid concentrations in spontaneously hypertensive rats fed a high-fat diet, Int. J. Mol. Sci., 13, 698, 10.3390/ijms13010698 · DOI
  106. Matos, 1987, S-adenosylmethionine: Studies on chemical and enzymatic synthesis, Biotechnol. Appl. Biochem., 9, 39, 10.1111/j.1470-8744.1987.tb00461.x · doi:10.1111/j.1470-8744.1987.tb00461.x
  107. Papakostas, 2003, S-adenosyl-methionine in depression: A comprehensive review of the literature, Curr. Psychiatry Rep., 5, 460, 10.1007/s11920-003-0085-2 · DOI
  108. Lieber, 2002, S-adenosyl-l-methionine: Its role in the treatment of liver disorders, Am. J. Clin. Nutr., 76, 1183, 10.1093/ajcn/76.5.1183S · DOI
  109. Bernardy, 2009, Treatment of fibromyalgia syndrome with antidepressants, J. Gen. Intern. Med., 301, 198
  110. Armando, 2013, Statistical optimization of culture conditions for biomass production of probiotic gut-borne Saccharomyces cerevisiae strain able to reduce fumonisin B1, J. Appl. Microbiol., 114, 1338, 10.1111/jam.12144 · DOI
  111. Rani, 2011, Optimization of culture conditions for bacterial cellulose production from Gluconacetobacter hansenii UAC09, Ann. Microbiol., 61, 781, 10.1007/s13213-011-0196-7 · doi:10.1007/s13213-011-0196-7
  112. Kwon, 2006, High concentration cultivation of Bifidobacterium bifidum in a submerged membrane bioreactor, Biotechnol. Prog., 22, 1591, 10.1021/bp060236s · doi:10.1021/bp060236s
  113. Dias, 1968, Calcium nutrition of Sphaerotilus growing in a continuous-flow apparatus, Appl. Microbiol., 16, 1364, 10.1128/am.16.9.1364-1369.1968 · doi:10.1128/am.16.9.1364-1369.1968
  114. Snellen, 1970, Morphogenesis and fine structure of Leucothrix mucor and effects of calcium deficiency, J. Bacteriol., 101, 240, 10.1128/jb.101.1.240-249.1970 · doi:10.1128/jb.101.1.240-249.1970
  115. Wright, 1981, Calcium-induced alteration of cellular morphology affecting the resistance of Lactobacillus acidophilus to freezing, Appl. Environ. Microbiol., 41, 807, 10.1128/aem.41.3.807-815.1981 · doi:10.1128/aem.41.3.807-815.1981
  116. Arena, 2015, Probiotic administration modifies the milk fatty acid profile, intestinal morphology, and intestinal fatty acid profile of goats, J. Dairy Sci., 98, 47, 10.3168/jds.2013-7805 · DOI
  117. Kojima, 1970, Necessity of calcium ion for cell division in Lactobacillus bifidus, J. Bacteriol., 104, 1010, 10.1128/jb.104.2.1010-1013.1970 · doi:10.1128/jb.104.2.1010-1013.1970
  118. Duranti, 2015, Insights from genomes of representatives of the human gut commensal Bifidobacterium bifidum, Environ. Microbiol., 17, 2515, 10.1111/1462-2920.12743 · DOI · Paper page
  119. Lugil, 2014, Investigation of the evolutionary development of the genus Bifidobacterium by comparative genomics, Appl. Environ. Microbiol., 80, 6383, 10.1128/AEM.02004-14 · DOI · Paper page
  120. Milani, 2016, Genomics of the genus Bifidobacterium reveals species-specific adaptation to the glycan-rich gut environment, Appl. Environ. Microbiol., 82, 980, 10.1128/AEM.03500-15 · DOI · Paper page
  121. Ventura, 2007, Genomics as a means to understand bacterial phylogeny and ecological adaptation: The case of bifidobacteria, Antonie van Leeuwenhoek, 91, 351, 10.1007/s10482-006-9122-6 · DOI
  122. Ventura, 2007, From bacterial genome to functionality; case bifidobacteria, Int. J. Food Mirobiol., 120, 2, 10.1016/j.ijfoodmicro.2007.06.011 · DOI
  123. Turroni, 2016, Deciphering bifidobacterial-mediaated metabolic interactions and their impact of gut microbiota by a multi-omics approach, ISME J., 10, 1656, 10.1038/ismej.2015.236 · DOI · Paper page
  124. Russell, 2011, Metabolic activities and probiotic potential of bifidobacteria, Int. J. Food Microbiol., 149, 88, 10.1016/j.ijfoodmicro.2011.06.003 · DOI · Paper page
  125. Milani, 2014, Genomic encyclopedia of type strains of the genus Bifidobacterium, Appl. Environ. Microbiol., 80, 6290, 10.1128/AEM.02308-14 · DOI · Paper page

Cited by

Metadata

Authors
Ku, S., Park, M., Ji, G., & You, H.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2016-09-14
Volume
17
Issue
9
Pages
1544
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2519778240
Cited by
106
References
17
FWCI
9.80
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.